Cargando…
Tankyrase inhibition ameliorates lipid disorder via suppression of PGC-1α PARylation in db/db mice
OBJECTIVE: Human TNKS, encoding tankyrase 1 (TNKS1), localizes to a susceptibility locus for obesity and type 2 diabetes mellitus (T2DM). Here, we addressed the therapeutic potential of G007-LK, a TNKS-specific inhibitor, for obesity and T2DM. METHODS: We administered G007-LK to diabetic db/db mice...
Autores principales: | Wang, Hong, Kuusela, Sara, Rinnankoski-Tuikka, Rita, Dumont, Vincent, Bouslama, Rim, Ramadan, Usama Abo, Waaler, Jo, Linden, Anni-Maija, Chi, Nai-Wen, Krauss, Stefan, Pirinen, Eija, Lehtonen, Sanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381423/ https://www.ncbi.nlm.nih.gov/pubmed/32317752 http://dx.doi.org/10.1038/s41366-020-0573-z |
Ejemplares similares
-
Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice
por: Hong, Yu Ah, et al.
Publicado: (2014) -
Tankyrase inhibition aggravates kidney injury in the absence of CD2AP
por: Kuusela, S, et al.
Publicado: (2016) -
Novel Small-Molecule PGC-1α Transcriptional Regulator With Beneficial Effects on Diabetic db/db Mice
por: Zhang, Li-Na, et al.
Publicado: (2013) -
Correction: Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice
Publicado: (2014) -
Tankyrase inhibition preserves osteoarthritic cartilage by coordinating cartilage matrix anabolism via effects on SOX9 PARylation
por: Kim, Sukyeong, et al.
Publicado: (2019)